GE HEALTHCARE TECHNOLOGIES INC. Research and Development Expense
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Research and Development Expense of $345.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-29
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for the quarter ending 2026-03-31 was $345.00M, a 0.29% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for the quarter ending 2025-12-31 was $323.00M, a 6.10% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for the quarter ending 2025-09-30 was $292.00M, a 7.59% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for the quarter ending 2025-06-30 was $302.00M, a 7.65% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for fiscal 2025 was $1.26B, a 3.89% decline from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for fiscal 2024 was $1.31B, a 8.80% increase from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for fiscal 2023 was $1.21B, a 17.45% increase from fiscal 2022.
- GE HEALTHCARE TECHNOLOGIES INC. research and development expense for fiscal 2022 was $1.03B, a 25.74% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $345.00M 10-Q · filed 2026-04-29 | $668.00M derived: sum of 2 quarters · filed 2026-04-29 | $960.00M derived: sum of 3 quarters · filed 2026-04-29 | $1.26B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $323.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $615.00M derived: sum of 2 quarters · filed 2026-02-04 | $917.00M derived: sum of 3 quarters · filed 2026-02-04 | $1.26B 10-K · filed 2026-02-04 |
| 2025-09-30 | $292.00M 10-Q · filed 2025-10-29 | $594.00M derived: sum of 2 quarters · filed 2025-10-29 | $937.00M 10-Q · filed 2025-10-29 | $1.28B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $302.00M 10-Q · filed 2025-07-30 | $646.00M 10-Q · filed 2025-07-30 | $990.00M derived: sum of 3 quarters · filed 2026-04-29 | $1.31B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $344.00M 10-Q · filed 2026-04-29 | $688.00M derived: sum of 2 quarters · filed 2026-04-29 | $1.00B derived: sum of 3 quarters · filed 2026-04-29 | $1.33B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $344.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $660.00M derived: sum of 2 quarters · filed 2026-02-04 | $987.00M derived: sum of 3 quarters · filed 2026-02-04 | $1.31B 10-K · filed 2026-02-04 |
| 2024-09-30 | $316.00M 10-Q · filed 2025-10-29 | $643.00M derived: sum of 2 quarters · filed 2025-10-29 | $967.00M 10-Q · filed 2025-10-29 | $1.28B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-06-30 | $327.00M 10-Q · filed 2025-07-30 | $651.00M 10-Q · filed 2025-07-30 | $966.00M derived: sum of 3 quarters · filed 2026-02-04 | $1.29B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-03-31 | $324.00M 10-Q · filed 2025-04-30 | $639.00M derived: sum of 2 quarters · filed 2026-02-04 | $961.00M derived: sum of 3 quarters · filed 2026-02-04 | $1.26B derived: sum of 4 quarters · filed 2026-02-04 |
| 2023-12-31 | $315.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $637.00M derived: sum of 2 quarters · filed 2026-02-04 | $935.00M derived: sum of 3 quarters · filed 2026-02-04 | $1.21B 10-K · filed 2026-02-04 |
| 2023-09-30 | $322.00M 10-Q · filed 2024-10-30 | $620.00M derived: sum of 2 quarters · filed 2024-10-30 | $890.00M 10-Q · filed 2024-10-30 | $1.16B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $298.00M 10-Q · filed 2024-07-31 | $568.00M 10-Q · filed 2024-07-31 | $839.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.10B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $270.00M 10-Q · filed 2024-04-30 | $541.00M derived: sum of 2 quarters · filed 2025-02-13 | $801.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.06B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $271.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $531.00M derived: sum of 2 quarters · filed 2025-02-13 | $788.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.03B 10-K · filed 2025-02-13 |
| 2022-09-30 | $260.00M 10-Q · filed 2023-10-31 | $517.00M derived: sum of 2 quarters · filed 2023-10-31 | $755.00M 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $257.00M 10-Q · filed 2023-07-25 | $495.00M 10-Q · filed 2023-07-25 | ||
| 2022-03-31 | $238.00M 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | $816.00M 10-K · filed 2024-02-06 |